Short-term weight increases during retatrutide treatment are most commonly caused by fluid retention, constipation, normal daily weight fluctuation, or inadequate appetite suppression during early dose titration not necessarily treatment failure
on average people regain 2/3 of what they lost, and the weight you gain back is pure fat
Depends entirely on whether you follow a systematic nutrition strategy or wing it
Firstly, hyperglycemia promotes local ANG II production in cardiomyocytes stimulating intracellular chymase and/or internalized prorenin, leading to diabetic cardiomyopathy
Effect of Semaglutide on Coronary Atherosclerosis Progression in Patients With Type II Diabetes: Rationale and Design of the Semaglutide Treatment on Coronary Progression Trial
This means less liquid under the skin, potentially less injection site discomfort, and faster absorption